nodes	percent_of_prediction	percent_of_DWPC	metapath
Bopindolol—Ketoprofen—CXCR1—melanoma	0.0334	0.369	CrCbGaD
Bopindolol—Carvedilol—HIF1A—melanoma	0.0231	0.255	CrCbGaD
Bopindolol—Carvedilol—VEGFA—melanoma	0.00929	0.103	CrCbGaD
Bopindolol—Ketoprofen—CXCL8—melanoma	0.00843	0.0931	CrCbGaD
Bopindolol—Mebendazole—ABCB1—melanoma	0.00483	0.0534	CrCbGaD
Bopindolol—Propafenone—ABCB1—melanoma	0.00265	0.0293	CrCbGaD
Bopindolol—Ketoprofen—PTGS2—melanoma	0.00246	0.0272	CrCbGaD
Bopindolol—Carvedilol—ABCB1—melanoma	0.00238	0.0263	CrCbGaD
Bopindolol—Ketoprofen—ALB—melanoma	0.00219	0.0242	CrCbGaD
Bopindolol—Propranolol—ABCB1—melanoma	0.00181	0.02	CrCbGaD
Bopindolol—HTR1B—Signaling Pathways—PIK3CG—melanoma	0.00018	0.000198	CbGpPWpGaD
Bopindolol—HTR1B—Signaling by GPCR—NRAS—melanoma	0.00018	0.000198	CbGpPWpGaD
Bopindolol—HTR1A—GPCR downstream signaling—IL2—melanoma	0.00018	0.000198	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—SPP1—melanoma	0.000179	0.000197	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—PRKCA—melanoma	0.000179	0.000197	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—ITGB3—melanoma	0.000179	0.000197	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—MAP2K2—melanoma	0.000179	0.000197	CbGpPWpGaD
Bopindolol—ADRB1—Signaling by GPCR—CXCL8—melanoma	0.000179	0.000196	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—E2F1—melanoma	0.000179	0.000196	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—EGF—melanoma	0.000178	0.000196	CbGpPWpGaD
Bopindolol—HTR1A—Signaling by GPCR—PIK3CB—melanoma	0.000178	0.000195	CbGpPWpGaD
Bopindolol—ADRB3—Signaling Pathways—CXCL8—melanoma	0.000178	0.000195	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—PDGFRA—melanoma	0.000177	0.000194	CbGpPWpGaD
Bopindolol—ADRB3—Signaling by GPCR—HRAS—melanoma	0.000177	0.000194	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—SPP1—melanoma	0.000175	0.000193	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—ITGB3—melanoma	0.000175	0.000192	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—PRKCA—melanoma	0.000175	0.000192	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—MAP2K2—melanoma	0.000175	0.000192	CbGpPWpGaD
Bopindolol—ADRB2—Signaling by GPCR—CXCL8—melanoma	0.000175	0.000192	CbGpPWpGaD
Bopindolol—ADRB3—Signaling Pathways—CDKN1B—melanoma	0.000174	0.000191	CbGpPWpGaD
Bopindolol—HTR1B—Signaling by GPCR—MAPK3—melanoma	0.000172	0.000189	CbGpPWpGaD
Bopindolol—ADRB3—GPCR downstream signaling—AKT1—melanoma	0.000172	0.000189	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—SPP1—melanoma	0.000172	0.000189	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—MAP2K2—melanoma	0.000171	0.000188	CbGpPWpGaD
Bopindolol—HTR1A—Signaling by GPCR—CXCL8—melanoma	0.000171	0.000188	CbGpPWpGaD
Bopindolol—ADRB1—Signaling by GPCR—IL2—melanoma	0.000171	0.000188	CbGpPWpGaD
Bopindolol—ADRB3—Signaling Pathways—CASP3—melanoma	0.00017	0.000187	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—TERT—melanoma	0.00017	0.000187	CbGpPWpGaD
Bopindolol—ADRB3—Signaling Pathways—IL2—melanoma	0.00017	0.000187	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—RAC1—melanoma	0.00017	0.000186	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—BRAF—melanoma	0.000169	0.000186	CbGpPWpGaD
Bopindolol—ADRB3—Signaling by GPCR—IL6—melanoma	0.000169	0.000186	CbGpPWpGaD
Bopindolol—ADRB2—Signaling by GPCR—IL2—melanoma	0.000167	0.000184	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—TERT—melanoma	0.000166	0.000183	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—RAC1—melanoma	0.000166	0.000182	CbGpPWpGaD
Bopindolol—ADRB3—Signaling Pathways—CCND1—melanoma	0.000166	0.000182	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—IGF1—melanoma	0.000165	0.000181	CbGpPWpGaD
Bopindolol—ADRB3—Signaling Pathways—CTNNB1—melanoma	0.000164	0.00018	CbGpPWpGaD
Bopindolol—HTR1B—Signaling by GPCR—MAPK1—melanoma	0.000164	0.00018	CbGpPWpGaD
Bopindolol—HTR1B—Signaling by GPCR—EGFR—melanoma	0.000164	0.00018	CbGpPWpGaD
Bopindolol—HTR1A—Signaling by GPCR—IL2—melanoma	0.000163	0.00018	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—TERT—melanoma	0.000163	0.000179	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—HIF1A—melanoma	0.000163	0.000179	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—RAC1—melanoma	0.000162	0.000178	CbGpPWpGaD
Bopindolol—ADRB3—Signaling Pathways—MMP9—melanoma	0.000161	0.000177	CbGpPWpGaD
Bopindolol—ADRB3—Signaling Pathways—CDKN1A—melanoma	0.00016	0.000176	CbGpPWpGaD
Bopindolol—ADRB3—Signaling Pathways—PTEN—melanoma	0.00016	0.000176	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—MAP2K1—melanoma	0.000159	0.000175	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—HIF1A—melanoma	0.000159	0.000175	CbGpPWpGaD
Bopindolol—ADRB3—Signaling Pathways—NFKB1—melanoma	0.000159	0.000175	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—PIK3CD—melanoma	0.000158	0.000174	CbGpPWpGaD
Bopindolol—HTR1B—GPCR downstream signaling—PIK3CA—melanoma	0.000157	0.000172	CbGpPWpGaD
Bopindolol—ADRB3—Signaling by GPCR—AKT1—melanoma	0.000156	0.000171	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—HIF1A—melanoma	0.000156	0.000171	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—KDR—melanoma	0.000156	0.000171	CbGpPWpGaD
Bopindolol—HTR1B—Signaling by GPCR—KRAS—melanoma	0.000155	0.00017	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—KDR—melanoma	0.000152	0.000167	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—FGF2—melanoma	0.000151	0.000166	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—FN1—melanoma	0.00015	0.000165	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—KDR—melanoma	0.000149	0.000164	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—NOTCH1—melanoma	0.000147	0.000161	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—FN1—melanoma	0.000146	0.000161	CbGpPWpGaD
Bopindolol—ADRB3—Signaling Pathways—VEGFA—melanoma	0.000144	0.000159	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—CD80—melanoma	0.000144	0.000158	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—NOTCH1—melanoma	0.000143	0.000158	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—APC—melanoma	0.000143	0.000158	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—PIK3CG—melanoma	0.000143	0.000158	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—KIT—melanoma	0.000143	0.000158	CbGpPWpGaD
Bopindolol—ADRB1—Signaling by GPCR—NRAS—melanoma	0.000143	0.000158	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—FN1—melanoma	0.000143	0.000157	CbGpPWpGaD
Bopindolol—ADRB3—Signaling Pathways—STAT3—melanoma	0.000143	0.000157	CbGpPWpGaD
Bopindolol—ADRB3—Signaling Pathways—NRAS—melanoma	0.000143	0.000157	CbGpPWpGaD
Bopindolol—HTR1B—Signaling by GPCR—PIK3CA—melanoma	0.000142	0.000156	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—MDM2—melanoma	0.000142	0.000156	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—EGF—melanoma	0.000142	0.000156	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—CD80—melanoma	0.00014	0.000154	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—APC—melanoma	0.00014	0.000154	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—KIT—melanoma	0.00014	0.000154	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—PIK3CG—melanoma	0.00014	0.000154	CbGpPWpGaD
Bopindolol—ADRB2—Signaling by GPCR—NRAS—melanoma	0.00014	0.000154	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—NOTCH1—melanoma	0.00014	0.000154	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—ERBB2—melanoma	0.00014	0.000154	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—EGF—melanoma	0.000139	0.000152	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—PIK3CB—melanoma	0.000138	0.000152	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—CD80—melanoma	0.000137	0.000151	CbGpPWpGaD
Bopindolol—ADRB1—Signaling by GPCR—MAPK3—melanoma	0.000137	0.000151	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—PIK3CG—melanoma	0.000137	0.000151	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—APC—melanoma	0.000137	0.000151	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—KIT—melanoma	0.000137	0.000151	CbGpPWpGaD
Bopindolol—HTR1A—Signaling by GPCR—NRAS—melanoma	0.000137	0.000151	CbGpPWpGaD
Bopindolol—ADRB3—Signaling Pathways—MAPK3—melanoma	0.000137	0.00015	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—EGF—melanoma	0.000135	0.000149	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—BRAF—melanoma	0.000135	0.000148	CbGpPWpGaD
Bopindolol—ADRB2—Signaling by GPCR—MAPK3—melanoma	0.000134	0.000148	CbGpPWpGaD
Bopindolol—ADRB3—Signaling Pathways—MYC—melanoma	0.000133	0.000146	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—CXCL8—melanoma	0.000132	0.000146	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—BRAF—melanoma	0.000132	0.000145	CbGpPWpGaD
Bopindolol—HTR1B—Signaling by GPCR—HRAS—melanoma	0.000132	0.000145	CbGpPWpGaD
Bopindolol—HTR1A—Signaling by GPCR—MAPK3—melanoma	0.000131	0.000144	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—IGF1—melanoma	0.000131	0.000144	CbGpPWpGaD
Bopindolol—ADRB1—Signaling by GPCR—MAPK1—melanoma	0.000131	0.000144	CbGpPWpGaD
Bopindolol—ADRB1—Signaling by GPCR—EGFR—melanoma	0.000131	0.000144	CbGpPWpGaD
Bopindolol—ADRB3—Signaling Pathways—MAPK1—melanoma	0.00013	0.000143	CbGpPWpGaD
Bopindolol—ADRB3—Signaling Pathways—EGFR—melanoma	0.00013	0.000143	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—CDKN1B—melanoma	0.000129	0.000142	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—BRAF—melanoma	0.000129	0.000142	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—IGF1—melanoma	0.000128	0.000141	CbGpPWpGaD
Bopindolol—HTR1B—GPCR downstream signaling—AKT1—melanoma	0.000128	0.000141	CbGpPWpGaD
Bopindolol—ADRB2—Signaling by GPCR—MAPK1—melanoma	0.000128	0.00014	CbGpPWpGaD
Bopindolol—ADRB2—Signaling by GPCR—EGFR—melanoma	0.000128	0.00014	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—CASP3—melanoma	0.000127	0.000139	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—MAP2K1—melanoma	0.000127	0.000139	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—IL2—melanoma	0.000127	0.000139	CbGpPWpGaD
Bopindolol—HTR1B—Signaling by GPCR—IL6—melanoma	0.000126	0.000139	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—PIK3CD—melanoma	0.000126	0.000138	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—IGF1—melanoma	0.000125	0.000138	CbGpPWpGaD
Bopindolol—HTR1A—Signaling by GPCR—MAPK1—melanoma	0.000125	0.000137	CbGpPWpGaD
Bopindolol—HTR1A—Signaling by GPCR—EGFR—melanoma	0.000125	0.000137	CbGpPWpGaD
Bopindolol—ADRB1—GPCR downstream signaling—PIK3CA—melanoma	0.000125	0.000137	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—MAP2K1—melanoma	0.000124	0.000136	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—CCND1—melanoma	0.000123	0.000136	CbGpPWpGaD
Bopindolol—ADRB1—Signaling by GPCR—KRAS—melanoma	0.000123	0.000136	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—PIK3CD—melanoma	0.000123	0.000135	CbGpPWpGaD
Bopindolol—ADRB3—Signaling Pathways—KRAS—melanoma	0.000123	0.000135	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—CTNNB1—melanoma	0.000122	0.000134	CbGpPWpGaD
Bopindolol—ADRB2—GPCR downstream signaling—PIK3CA—melanoma	0.000122	0.000134	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—MAP2K1—melanoma	0.000121	0.000133	CbGpPWpGaD
Bopindolol—ADRB2—Signaling by GPCR—KRAS—melanoma	0.000121	0.000133	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—FGF2—melanoma	0.000121	0.000133	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—PIK3CD—melanoma	0.00012	0.000132	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—MMP9—melanoma	0.00012	0.000132	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—CDKN1A—melanoma	0.000119	0.000131	CbGpPWpGaD
Bopindolol—HTR1A—GPCR downstream signaling—PIK3CA—melanoma	0.000119	0.000131	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—PTEN—melanoma	0.000119	0.000131	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—NFKB1—melanoma	0.000119	0.00013	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—FGF2—melanoma	0.000118	0.00013	CbGpPWpGaD
Bopindolol—HTR1A—Signaling by GPCR—KRAS—melanoma	0.000118	0.00013	CbGpPWpGaD
Bopindolol—HTR1B—Signaling by GPCR—AKT1—melanoma	0.000116	0.000128	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—FGF2—melanoma	0.000115	0.000127	CbGpPWpGaD
Bopindolol—ADRB1—Signaling by GPCR—PIK3CA—melanoma	0.000113	0.000125	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—MDM2—melanoma	0.000113	0.000124	CbGpPWpGaD
Bopindolol—ADRB3—Signaling Pathways—PIK3CA—melanoma	0.000113	0.000124	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—ERBB2—melanoma	0.000111	0.000122	CbGpPWpGaD
Bopindolol—ADRB2—Signaling by GPCR—PIK3CA—melanoma	0.000111	0.000122	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—MDM2—melanoma	0.00011	0.000121	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—PIK3CB—melanoma	0.00011	0.000121	CbGpPWpGaD
Bopindolol—ADRB3—Signaling Pathways—TP53—melanoma	0.000109	0.00012	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—ERBB2—melanoma	0.000109	0.00012	CbGpPWpGaD
Bopindolol—HTR1A—Signaling by GPCR—PIK3CA—melanoma	0.000108	0.000119	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—MDM2—melanoma	0.000108	0.000119	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—VEGFA—melanoma	0.000108	0.000118	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—PIK3CB—melanoma	0.000107	0.000118	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—STAT3—melanoma	0.000107	0.000117	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—ERBB2—melanoma	0.000106	0.000117	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—NRAS—melanoma	0.000106	0.000117	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—CXCL8—melanoma	0.000106	0.000116	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—PIK3CB—melanoma	0.000105	0.000115	CbGpPWpGaD
Bopindolol—ADRB1—Signaling by GPCR—HRAS—melanoma	0.000105	0.000115	CbGpPWpGaD
Bopindolol—ADRB3—Signaling Pathways—HRAS—melanoma	0.000104	0.000115	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—CXCL8—melanoma	0.000103	0.000113	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—CDKN1B—melanoma	0.000103	0.000113	CbGpPWpGaD
Bopindolol—ADRB2—Signaling by GPCR—HRAS—melanoma	0.000103	0.000113	CbGpPWpGaD
Bopindolol—ADRB1—GPCR downstream signaling—AKT1—melanoma	0.000102	0.000112	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—MAPK3—melanoma	0.000102	0.000112	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—CASP3—melanoma	0.000101	0.000111	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—CXCL8—melanoma	0.000101	0.000111	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—IL2—melanoma	0.000101	0.000111	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—CDKN1B—melanoma	0.000101	0.000111	CbGpPWpGaD
Bopindolol—ADRB1—Signaling by GPCR—IL6—melanoma	0.0001	0.00011	CbGpPWpGaD
Bopindolol—HTR1A—Signaling by GPCR—HRAS—melanoma	0.0001	0.00011	CbGpPWpGaD
Bopindolol—ADRB3—Signaling Pathways—IL6—melanoma	9.98e-05	0.00011	CbGpPWpGaD
Bopindolol—ADRB2—GPCR downstream signaling—AKT1—melanoma	9.97e-05	0.00011	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—MYC—melanoma	9.9e-05	0.000109	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—CASP3—melanoma	9.88e-05	0.000109	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—IL2—melanoma	9.86e-05	0.000108	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—CDKN1B—melanoma	9.86e-05	0.000108	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—CCND1—melanoma	9.83e-05	0.000108	CbGpPWpGaD
Bopindolol—ADRB2—Signaling by GPCR—IL6—melanoma	9.81e-05	0.000108	CbGpPWpGaD
Bopindolol—HTR1A—GPCR downstream signaling—AKT1—melanoma	9.75e-05	0.000107	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—CTNNB1—melanoma	9.73e-05	0.000107	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—MAPK1—melanoma	9.68e-05	0.000106	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—EGFR—melanoma	9.68e-05	0.000106	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—CASP3—melanoma	9.66e-05	0.000106	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—IL2—melanoma	9.64e-05	0.000106	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—CCND1—melanoma	9.61e-05	0.000106	CbGpPWpGaD
Bopindolol—HTR1A—Signaling by GPCR—IL6—melanoma	9.6e-05	0.000106	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—MMP9—melanoma	9.54e-05	0.000105	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—CTNNB1—melanoma	9.52e-05	0.000105	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—CDKN1A—melanoma	9.51e-05	0.000105	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—PTEN—melanoma	9.49e-05	0.000104	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—NFKB1—melanoma	9.44e-05	0.000104	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—CCND1—melanoma	9.4e-05	0.000103	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—MMP9—melanoma	9.33e-05	0.000103	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—CTNNB1—melanoma	9.31e-05	0.000102	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—CDKN1A—melanoma	9.3e-05	0.000102	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—PTEN—melanoma	9.28e-05	0.000102	CbGpPWpGaD
Bopindolol—ADRB1—Signaling by GPCR—AKT1—melanoma	9.26e-05	0.000102	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—NFKB1—melanoma	9.24e-05	0.000102	CbGpPWpGaD
Bopindolol—ADRB3—Signaling Pathways—AKT1—melanoma	9.21e-05	0.000101	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—KRAS—melanoma	9.15e-05	0.000101	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—MMP9—melanoma	9.13e-05	0.0001	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—CDKN1A—melanoma	9.1e-05	0.0001	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—PTEN—melanoma	9.07e-05	9.98e-05	CbGpPWpGaD
Bopindolol—ADRB2—Signaling by GPCR—AKT1—melanoma	9.05e-05	9.95e-05	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—NFKB1—melanoma	9.03e-05	9.93e-05	CbGpPWpGaD
Bopindolol—HTR1A—Signaling by GPCR—AKT1—melanoma	8.85e-05	9.73e-05	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—VEGFA—melanoma	8.57e-05	9.42e-05	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—STAT3—melanoma	8.48e-05	9.33e-05	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—NRAS—melanoma	8.46e-05	9.31e-05	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—PIK3CA—melanoma	8.4e-05	9.24e-05	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—VEGFA—melanoma	8.38e-05	9.22e-05	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—STAT3—melanoma	8.3e-05	9.13e-05	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—NRAS—melanoma	8.28e-05	9.1e-05	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—VEGFA—melanoma	8.2e-05	9.01e-05	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—TP53—melanoma	8.13e-05	8.94e-05	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—STAT3—melanoma	8.12e-05	8.92e-05	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—MAPK3—melanoma	8.11e-05	8.91e-05	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—NRAS—melanoma	8.1e-05	8.9e-05	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—MAPK3—melanoma	7.93e-05	8.72e-05	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—MYC—melanoma	7.88e-05	8.67e-05	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—HRAS—melanoma	7.77e-05	8.55e-05	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—MAPK3—melanoma	7.75e-05	8.52e-05	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—MAPK1—melanoma	7.71e-05	8.48e-05	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—MYC—melanoma	7.71e-05	8.48e-05	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—EGFR—melanoma	7.71e-05	8.48e-05	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—MAPK1—melanoma	7.54e-05	8.3e-05	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—EGFR—melanoma	7.54e-05	8.29e-05	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—MYC—melanoma	7.54e-05	8.29e-05	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—IL6—melanoma	7.44e-05	8.18e-05	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—MAPK1—melanoma	7.38e-05	8.11e-05	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—EGFR—melanoma	7.38e-05	8.11e-05	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—KRAS—melanoma	7.28e-05	8.01e-05	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—KRAS—melanoma	7.13e-05	7.84e-05	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—KRAS—melanoma	6.97e-05	7.66e-05	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—AKT1—melanoma	6.87e-05	7.55e-05	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—PIK3CA—melanoma	6.69e-05	7.36e-05	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—PIK3CA—melanoma	6.55e-05	7.2e-05	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—TP53—melanoma	6.47e-05	7.12e-05	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—PIK3CA—melanoma	6.4e-05	7.04e-05	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—TP53—melanoma	6.33e-05	6.96e-05	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—TP53—melanoma	6.19e-05	6.81e-05	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—HRAS—melanoma	6.19e-05	6.81e-05	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—HRAS—melanoma	6.06e-05	6.66e-05	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—IL6—melanoma	5.93e-05	6.52e-05	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—HRAS—melanoma	5.92e-05	6.51e-05	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—IL6—melanoma	5.8e-05	6.37e-05	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—IL6—melanoma	5.67e-05	6.23e-05	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—AKT1—melanoma	5.47e-05	6.01e-05	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—AKT1—melanoma	5.35e-05	5.88e-05	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—AKT1—melanoma	5.23e-05	5.75e-05	CbGpPWpGaD
